Viewing Study NCT04692051


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:30 PM
Study NCT ID: NCT04692051
Status: UNKNOWN
Last Update Posted: 2020-12-31
First Post: 2020-12-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor: Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module